Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes

被引:1
作者
Van Ark-Otte, J [1 ]
Samelis, G [1 ]
Rubio, G [1 ]
Saez, JBL [1 ]
Pinedo, HM [1 ]
Giaccone, G [1 ]
机构
[1] Free Univ Amsterdam Hosp, Dept Oncol, NL-1081 HV Amsterdam, Netherlands
关键词
P-glycoprotein; multidrug resistance protein; taxol; taxotere; rhizoxin;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Drug sensitivity was studied for the tubulin inhibitors taxol, taxotere, rhizoxin and for doxorubucin and cisplatin, in human lung and breast cancer cell lines, including drug-selected cell lines, overexpressing the membrane transporter P-glycoprotein (Pgp) or the multidrug resistance protein (MRP). All tubulin-inhibiting agents were more potent than doxorubicin and cisplatin in all cell lines. In the drug resistance-selected cell lines (doxorubicin or mitoxantrone resistant) there was cross-resistance between the tubulin inhibitors and the selecting agent; however, MRP overexpressing cells were relatively less resistant to taxanes than the Pgp overexpressing cells. Polymerization of microtubules after exposure to taxol was observed in drug sensitive cell lines, but not in resistant cell lines, even at high taxol concentrations and after long exposure times. In the Pgp overexpressing cell lines, steady accumulation of C-14-taxol was defective and could be reverted by verapamil. MRP overexpressing cells did not have a significant accumulation defect of taxol, compared to the parental cell lines, and verapamil did not have any effect. These data confirm that the Pgp overexpression is an important mechanism of resistance to taxanes and rhizoxin in human lung and breast tumor cells. However, the presence of mechanims other than transport defects may play an important role in non-Pgp expressing cells, and these may include an altered function of tubulins.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 43 条
[31]  
ROBERTS JR, 1990, CANCER RES, V50, P710
[32]   DRUG-THERAPY - PACLITAXEL (TAXOL) [J].
ROWINSKY, EK ;
DONEHOWER, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (15) :1004-1014
[33]   THE DRUG RESISTANCE-RELATED PROTEIN LRP IS THE HUMAN MAJOR VAULT PROTEIN [J].
SCHEFFER, GL ;
WIJNGAARD, PLJ ;
FLENS, MJ ;
IZQUIERDO, MA ;
SLOVAK, ML ;
PINEDO, HM ;
MEIJER, CJLM ;
CLEVERS, HC ;
SCHEPER, RJ .
NATURE MEDICINE, 1995, 1 (06) :578-582
[34]  
SCHEPER RJ, 1993, CANCER RES, V53, P1475
[35]   TAXOL STABILIZES MICROTUBULES IN MOUSE FIBROBLAST CELLS [J].
SCHIFF, PB ;
HORWITZ, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (03) :1561-1565
[36]   IN-VITRO CYTOTOXIC ACTIVITY OF TAXOL(R) AND TAXOTERE ON PRIMARY CULTURES AND ESTABLISHED CELL-LINES OF HUMAN OVARIAN-CANCER [J].
SILVESTRINI, R ;
ZAFFARONI, N ;
ORLANDI, L ;
ORIANA, S .
STEM CELLS, 1993, 11 (06) :528-535
[37]  
SULLIVAN AS, 1990, CANCER RES, V50, P4277
[38]  
TAKATORI T, 1995, CANCER CHEMOTH PHARM, V35, P283, DOI 10.1007/BF00689446
[39]   DIFFERENT MECHANISMS OF DECREASED DRUG ACCUMULATION IN DOXORUBICIN AND MITOXANTRONE RESISTANT VARIANTS OF THE MCF7 HUMAN BREAST-CANCER CELL-LINE [J].
TAYLOR, CW ;
DALTON, WS ;
PARRISH, PR ;
GLEASON, MC ;
BELLAMY, WT ;
THOMPSON, FH ;
ROE, DJ ;
TRENT, JM .
BRITISH JOURNAL OF CANCER, 1991, 63 (06) :923-929
[40]  
TSUTO T, 1986, CANCER RES, V46, P381